NFKB1 and tuberculosis: To ensure that the combined treatment of pasakbumin A and anti-TB drug effectively controls intracellular Mtb growth by inducing autophagy through ERK1/2- and NF-κB-mediated signaling pathway, we investigated intracellular Mtb growth using each inhibitors to block these signaling in presence or absence of anti-TB drug, RMP.